PEOPLE ON THE MOVE
Prasad Raje named new CEO of Nanotherapeutics
Prasad Raje, Ph.D., has been appointed President and CEO of Nanotherapeutics Inc., succeeding James Matthew, the interim CEO.
Nanotherapeutics is a Florida, US-based CDMO with facilities in the Maryland and Czech Republic for manufacturing of proteins, antibodies, viral vaccines and gene therapy products.
Prior to joining Nanotherapeutics, Raje held positions at EAG Laboratories, a global CRO specializing in analytical and toxicology services, and Cambridge Major Laboratories.
He also served at various leadership roles at Smithers Pharma Services, Albany Molecular Research and AMRI India Pvt. Ltd.
